Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.74 is 41% above its 3-year average of 4.77, around the middle of its 3-year range (0.00–11.26).
As of the fiscal period ended Tuesday, June 30, 2026. 10.00% above its 12-month average of 6.13.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.74.
QUICK RATIO (ACID-TEST)
6.74
QUICK RATIO (ACID-TEST) AVG TTM
6.13
QUICK RATIO (ACID-TEST) AVG 3Y
4.63
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.00%
CURRENT VS 3Y AVG
+45.62%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+101.30%
vs the sector median at left
Market Cap
$840.18M
Quick Ratio (Acid-Test)
4.03
TTM Avg
6.29
3Y Avg
5.71
5Y Avg
7.79
Market Cap
$838.84M
Quick Ratio (Acid-Test)
25.06
TTM Avg
12.67
3Y Avg
12.67
5Y Avg
12.67
Market Cap
$852.84M
Quick Ratio (Acid-Test)
0.76
TTM Avg
0.79
3Y Avg
0.88
5Y Avg
1.73
Market Cap
$853.28M
Quick Ratio (Acid-Test)
7.55
TTM Avg
6.94
3Y Avg
6.93
5Y Avg
8.87
Market Cap
$831.65M
Quick Ratio (Acid-Test)
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$854.88M
Quick Ratio (Acid-Test)
1.79
TTM Avg
2.17
3Y Avg
1.93
5Y Avg
2.04
Market Cap
$826.46M
Quick Ratio (Acid-Test)
7.96
TTM Avg
6.81
3Y Avg
6.62
5Y Avg
6.62
Market Cap
$869.18M
Quick Ratio (Acid-Test)
3.05
TTM Avg
34.00
3Y Avg
26.34
5Y Avg
26.34
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alumis Inc. (ALMS) | $843.04M | 6.74 | 6.13 | 4.63 | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $840.18M | 4.03 | 6.29 | 5.71 | 7.79 |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $838.84M | 25.06 | 12.67 | 12.67 | 12.67 |
| QuidelOrtho Corporation (QDEL)vs › | $852.84M | 0.76 | 0.79 | 0.88 | 1.73 |
| SI-BONE, Inc. (SIBN)vs › | $853.28M | 7.55 | 6.94 | 6.93 | 8.87 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $831.65M | 9.52 | 4.26 | 6.09 | 7.80 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $854.88M | 1.79 | 2.17 | 1.93 | 2.04 |
| Beta Bionics, Inc. (BBNX)vs › | $826.46M | 7.96 | 6.81 | 6.62 | 6.62 |
| SL Science Holding Ltd (SLBT)vs › | $869.18M | 3.05 | 34.00 | 26.34 | 26.34 |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $872.01M | 11.36 | 7.20 | 7.20 | 7.20 |
Quick Ratio
6.74
Excludes inventory
Current Ratio
6.74
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.74 |
| 2026-03-31 | 7.51 |
| 2025-12-31 | 4.34 |
| 2025-09-30 | 6.01 |
| 2025-06-30 | 6.05 |
| 2025-03-31 | 3.73 |
| 2024-12-31 | 6.01 |
| 2024-09-30 | 11.26 |
| 2024-06-30 | 6.73 |
| 2024-03-31 | 5.89 |
| 2023-12-31 | 2.56 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
